BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 26803429)

  • 1. Progression of carotid vascular damage and cardiovascular events in non-alcoholic fatty liver disease patients compared to the general population during 10 years of follow-up.
    Fracanzani AL; Tiraboschi S; Pisano G; Consonni D; Baragetti A; Bertelli C; Norata D; Valenti L; Grigore L; Porzio M; Catapano A; Fargion S
    Atherosclerosis; 2016 Mar; 246():208-13. PubMed ID: 26803429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease.
    Chen Y; Xu M; Wang T; Sun J; Sun W; Xu B; Huang X; Xu Y; Lu J; Li X; Wang W; Bi Y; Ning G
    Atherosclerosis; 2015 Jul; 241(1):145-50. PubMed ID: 25988358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement in non-alcoholic fatty liver disease severity is associated with a reduction in carotid intima-media thickness progression.
    Bhatia L; Scorletti E; Curzen N; Clough GF; Calder PC; Byrne CD
    Atherosclerosis; 2016 Mar; 246():13-20. PubMed ID: 26748347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis.
    Adinolfi LE; Restivo L; Zampino R; Guerrera B; Lonardo A; Ruggiero L; Riello F; Loria P; Florio A
    Atherosclerosis; 2012 Apr; 221(2):496-502. PubMed ID: 22385985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children and adolescents.
    Pacifico L; Bonci E; Andreoli G; Romaggioli S; Di Miscio R; Lombardo CV; Chiesa C
    Nutr Metab Cardiovasc Dis; 2014 Jul; 24(7):737-43. PubMed ID: 24656140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-alcoholic fatty liver disease is a strong predictor of coronary artery calcification in metabolically healthy subjects: A cross-sectional, population-based study in middle-aged subjects.
    Gummesson A; Strömberg U; Schmidt C; Kullberg J; Angerås O; Lindgren S; Hjelmgren O; Torén K; Rosengren A; Fagerberg B; Brandberg J; Bergström G
    PLoS One; 2018; 13(8):e0202666. PubMed ID: 30133541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD.
    Fernández-Laso V; Sastre C; Valdivielso JM; Betriu A; Fernández E; Egido J; Martín-Ventura JL; Blanco-Colio LM
    Clin J Am Soc Nephrol; 2016 Mar; 11(3):413-22. PubMed ID: 26728587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease (NAFLD) and cardiovascular risk in renal transplant recipients.
    Mikolasevic I; Racki S; Zaputovic L; Lukenda V; Sladoje-Martinovic B; Orlic L
    Kidney Blood Press Res; 2014; 39(4):308-14. PubMed ID: 25300437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence, Characteristics, and Prognostic Associations of Carotid Plaque Among People Living With HIV.
    Janjua SA; Staziaki PV; Szilveszter B; Takx RAP; Mayrhofer T; Hennessy O; Emami HA; Park J; Ivanov A; Hallett TR; Lu MT; Romero JM; Grinspoon SK; Hoffmann U; Zanni MV; Neilan TG
    Circ Cardiovasc Imaging; 2017 Oct; 10(10):. PubMed ID: 29021257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between nonalcoholic fatty liver disease and subclinical atherosclerosis: a cross-sectional study on population over 40 years old.
    Zheng J; Zhou Y; Zhang K; Qi Y; An S; Wang S; Zhao X; Tang YD
    BMC Cardiovasc Disord; 2018 Jul; 18(1):147. PubMed ID: 30012085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease is an independent risk factor for atherosclerosis in young adult men.
    Ozturk K; Uygun A; Guler AK; Demirci H; Ozdemir C; Cakir M; Sakin YS; Turker T; Sari S; Demirbas S; Karslıoğlu Y; Saglam M
    Atherosclerosis; 2015 Jun; 240(2):380-6. PubMed ID: 25875390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of carotid intima-media thickness as predictor of vascular events: results from the IMPROVE study.
    Baldassarre D; Veglia F; Hamsten A; Humphries SE; Rauramaa R; de Faire U; Smit AJ; Giral P; Kurl S; Mannarino E; Grossi E; Paoletti R; Tremoli E;
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2273-9. PubMed ID: 23825364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carotid plaque burden as a measure of subclinical atherosclerosis: comparison with other tests for subclinical arterial disease in the High Risk Plaque BioImage study.
    Sillesen H; Muntendam P; Adourian A; Entrekin R; Garcia M; Falk E; Fuster V
    JACC Cardiovasc Imaging; 2012 Jul; 5(7):681-9. PubMed ID: 22789936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome.
    Kim HC; Kim DJ; Huh KB
    Atherosclerosis; 2009 Jun; 204(2):521-5. PubMed ID: 18947828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High titer of anti-citrullinated peptide antibody is a risk factor for severe carotid atherosclerotic plaque in patients with rheumatoid arthritis: the TOMORROW study.
    Okano T; Inui K; Sugioka Y; Sugioka K; Matsumura Y; Takahashi S; Tada M; Mamoto K; Wakitani S; Koike T; Nakamura H
    Int J Rheum Dis; 2017 Aug; 20(8):949-959. PubMed ID: 28627096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and its association with cardiovascular disease.
    Vanjiappan S; Hamide A; Ananthakrishnan R; Periyasamy SG; Mehalingam V
    Diabetes Metab Syndr; 2018 Jul; 12(4):479-482. PubMed ID: 29402657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic fatty liver disease is associated with late but not early atherosclerotic lesions in Chinese inpatients with type 2 diabetes.
    Guo K; Zhang L; Lu J; Yu H; Wu M; Bao Y; Chen H; Jia W
    J Diabetes Complications; 2017 Jan; 31(1):80-85. PubMed ID: 27742552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of carotid intima-media thickness and carotid plaques on the development of micro- and macrovascular complications in individuals with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study.
    Cardoso CRL; Salles GC; Leite NC; Salles GF
    Cardiovasc Diabetol; 2019 Jan; 18(1):2. PubMed ID: 30630491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between nonalcoholic fatty liver disease and carotid artery inflammation evaluated by 18F-fluorodeoxyglucose positron emission tomography.
    Moon SH; Noh TS; Cho YS; Hong SP; Hyun SH; Choi JY; Kim BT; Lee KH
    Angiology; 2015 May; 66(5):472-80. PubMed ID: 24904182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.